Back to Avoro Capital Advisors LLC Avoro Capital Advisors LLC

TGTXTGTX

Showing 0 of 3 quarters

Position history for Avoro Capital Advisors LLCAvoro Capital Advisors LLC's holdings in TG Therapeutics, Inc.

No. Avoro Capital Advisors exited its TGTX (TG Therapeutics) position in Q2 2020. Its Q1 2020 13F listed 800,000 shares worth $7.9M. Avoro Capital Advisors first reported TGTX in Q4 2019 and held it in 2 quarterly 13F filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used